Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
May act as a receptor in regulating T-cell proliferation.. Zusätzlich bieten wir Ihnen CD5 Proteine (20) und CD5 Kits (16) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 1283 products:
Human Monoclonal CD5 Primary Antibody für IHC (p) - ABIN1687421
Galgani, Insabato, Calì, Della Gatta, Mirra, Papaccio, Santopaolo, Alviggi, Mollo, Strina, Matarese, Beguinot, De Placido, Ulianich: Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity. in Fertility and sterility 2015
Zeige alle 21 Referenzen für ABIN1687421
Rat (Rattus) Monoclonal CD5 Primary Antibody für FACS, IHC (fro) - ABIN120388
Dallman, Thomas, Green: MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. in European journal of immunology 1984
Zeige alle 4 Referenzen für ABIN120388
Rat (Rattus) Monoclonal CD5 Primary Antibody für FACS - ABIN120386
Barclay: The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. in Immunology 1981
Zeige alle 3 Referenzen für ABIN120386
Human Monoclonal CD5 Primary Antibody für FACS - ABIN951342
Raman, Kuo, Deshane, Litchfield, Kimberly: Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. in The Journal of biological chemistry 1998
Zeige alle 3 Referenzen für ABIN951342
Human Monoclonal CD5 Primary Antibody für IHC (fro), IHC (p) - ABIN114633
Kasaian, Ikematsu, Casali: CD5+ B lymphocytes. in Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991
Zeige alle 2 Referenzen für ABIN114633
Human Monoclonal CD5 Primary Antibody für FACS, IHC (p) - ABIN1106434
Wang, Kvalheim, Kvaløy, Beiske, Jakobsen, Wijdenes, Pihl, Fodstad: An effective immunomagnetic method for bone marrow purging in T cell malignancies. in Bone marrow transplantation 1992
Human Polyclonal CD5 Primary Antibody für WB - ABIN2774224
Garza-Garcia, Esposito, Rieping, Harris, Briggs, Brown, Driscoll: Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5. in Journal of molecular biology 2008
Human Monoclonal CD5 Primary Antibody für FACS - ABIN1106444
Garnache-Ottou, Chaperot, Biichle, Ferrand, Remy-Martin, Deconinck, de Tailly, Bulabois, Poulet, Kuhlein, Jacob, Salaun, Arock, Drenou, Schillinger, Seilles, Tiberghien, Bensa, Plumas, Saas: Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. in Blood 2005
Mouse (Murine) Monoclonal CD5 Primary Antibody für FACS - ABIN120098
Cobbold, Jayasuriya, Nash, Prospero, Waldmann: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. in Nature 1985
the reduction in the positive selection conferred by CD5 overexpression was unaffected by SHP-1 deficiency.
In mice lacking functional KDELR1, surviving naive T cells expressed significantly higher levels of CD5, a surrogate marker of TCR self-reactivity.
In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. The results demonstrate a critical role of CD5(+) B cells in promoting cancer.
CD5 and CD72 (zeige CD72 Antikörper) play a critical role in maintaining regulatory T and B cell homeostasis
CD5 promoted Treg cell induction in response to self and tolerizing antigens by blocking mTOR (zeige FRAP1 Antikörper) activation.
Data indicate that CD5-casein kinase 2 (CK2 (zeige CSNK2A1 Antikörper)) signaling is necessary for efficient nuclear localization of orphan nuclear receptor (zeige NR1D1 Antikörper) ROR (zeige RORB Antikörper)-gammaT (RORgammat).
These results support the notion that the distal cytoplasmic domain of CD5, including Y463, plays a relevant role in the downmodulation of TCR signals in thymocytes via c-Cbl (zeige CBL Antikörper).
Although the percentage of CD1d (zeige CD1D Antikörper)(hi)CD5+ subset in splenic B cells does not change significantly, percent IL-10 (zeige IL10 Antikörper)-expressing cells among total splenic B cells or the CD1dhiCD5+ population significantly increases 3-7 days after rCRT/39-272 administration
Different CD5 expression levels influence the proliferation dynamics of activated naive CD4 (zeige CD4 Antikörper)+ T cells while leaving the conversion rate of those cells into memory cells unaffected.
Data show several homologies across human, rat and mouse in the kinetic of loss of several LAgs such as CD5, CD4 (zeige CD4 Antikörper) and CD28 (zeige CD28 Antikörper).
Thus, trans-signaling of IL-6 (zeige IL6 Antikörper) can only occur via sIL (zeige PMEL Antikörper)-6R, but not sCD5 (zeige SCD5 Antikörper).
The major proportion of CD5(low) B cells in patients are leukemic, thus identifying CD5(low) B cells as an important component of CLL, with implications for CLL pathogenesis, clinical monitoring, and the development of anti-CD5-directed therapies.
the CD5 Pro224-Ala471 haplotype in homozygosis improved melanoma survival in the entire set of patients (HR = 0.27, 95% CI 0.11-0.67, Adj. p = 0.005). These findings highlight the relevance of genetic variability in immune-related genes for clinical outcome in melanoma.
R-EPOCH therapy does not seem to impact the known poorer prognosis of patients with de novo CD5+ diffuse large B-cell lymphoma , and CD5 expression was still an independent prognostic factor in R-EPOCH-treated patients with diffuse large B-cell lymphoma.
CD5+B lymphocytes were increased and activated in autoimmune hemolytic anemia patients.
This study confirms the poor prognosis of de novo CD5+ DLBCL in a large multi-center cohort despite initial rituximab-containing chemotherapy and suggests that stem cell transplantation fails to salvage the majority of these patients.
5.2 % were positive for CD5 and 5.7 % positive for epstein-Barr virus encoded RNA
CD5 polymorphisms are associated with systemic lupus erythematosus.
three tyrosine-based domains within CD5 cytoplasmic tail promote T-cell survival through non-overlapping mechanisms
A case of mantle cell lymphoma with a unique pattern of CD5 negative to positive expression switching in relapse.
Findings suggest that development, selection and function of different B- and T-cell subsets may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like (zeige CD5L Antikörper) molecules expressed on T cells compared to B (zeige TDO2 Antikörper) cells.
May act as a receptor in regulating T-cell proliferation.
, t-cell surface glycoprotein CD5-like
, T-cell surface glycoprotein CD5
, lymphocyte antigen 1
, CD5 antigen (p56-62)
, lymphocyte antigen T1/Leu-1
, CD5 antigen
, Lymphocyte antigen CD5
, CD74 antigen, invariant polypeptide of major
, lymphocyte receptor CD5